IPAD-DB ID | S00826 |
Name | Hexyl caffeate |
Category | Synthetic compounds |
2D Structure |
|
3D Structure | |
Molecular Formula | C 1 5 H 2 0 O 4 |
Molecular Weight | 264.32 g/mol |
IUPAC Name | hexyl(E)-3-(3, 4-dihydroxyphenyl)prop-2-enoate |
InChI | InChI=1S/C15H20O4/c1-2-3-4-5-10-19-15(18)9-7-12-6-8-13(16)14(17)11-12/h6-9, 11, 16-17H, 2-5, 10H2, 1H3/b9-7+ |
InChIKey | NNQZIMJGJLIECD-VQHVLOKHSA-N |
Canonical SMILES | CCCCCCOC(=O)C=CC1=CC(=C(C=C1)O)O |
PubChem CID | 21716170 |
DrugBank Accession Number | - |
CAS Registry Number | 142234-82-0 |
Molecular Weight(Computed by SwissADME) | 264.32 |
Hac(Computed by SwissADME) | 19 |
Volume(Computed by ADMETlab 2.0) | 281.418 |
Density(Computed by ADMETlab 2.0) | 0.939 |
nRing(Computed by ADMETlab 2.0) | 1 |
MaxRing(Computed by ADMETlab 2.0) | 6 |
nHet(Computed by ADMETlab 2.0) | 4 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 8 |
Flexibility(Computed by ADMETlab 2.0) | 1 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | -3.404 |
LogD(Computed by ADMETlab 2.0) | 3.261 |
logP(Computed by ADMETlab 2.0) | 3.945 |
TPSA(Computed by SwissADME) | 66.76 |
Hbond Acceptor(Computed by SwissADME) | 4 |
Hbond Donor(Computed by SwissADME) | 2 |
Rotatable Bonds(Computed by SwissADME) | 8 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | Yes |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | Yes |
CYP2C19 Inhibitor(Computed by SwissADME) | Yes |
CYP2C9 Inhibitor(Computed by SwissADME) | Yes |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -4.64 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 0 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 0 |
Bioavailability Score(Computed by SwissADME) | 0.55 |